Cardiac Rhythm Device: Implantation, Management, and Follow Up

Memo

The Cardiac Rhythm Device Summit will provide an update on the indications, follow up, and management of cardiac rhythm technology, emphasizing clinical pearls. Hundreds of thousands of patients receive cardiac rhythm devices each year for brady or tachyarrhythmis and heart failure. In addition, the number of people who may benefit from an implantable cardioverter defibrillator (ICD) and/or cardiac resynchronization device (CRT) has substantially increased in the past decade. Evolving device technology has increased programming complexity, follow-up, and management. Cardiac implantable device management related to electrophysiology remains a major part of daily practice for cardiologists, electrophysiologists, and non-physician caregivers involved in the management of these devices. LEARNING OBJECTIVES• Describe the current indications for pacemaker, ICD, subcutaneous ICD, and resynchronization therapies• Recognize upcoming technologies such as leadless and epicardial devices• Interpret diagnostic material (electrocardiograms, impedance, radiography, and other sources) to troubleshoot suspected implantable device malfunction• Discuss CIED related common issues such as management of device patients having MRI, radiation, infection and extract implantable devices• Identify the current capabilities and roles of remote monitoring to manage patients with cardiovascular risk and disease• Recognize precise cardiac anatomy to facilitate lead placement INTENDED AUDIENCEThe symposium is designed for cardiologists, internists, family practitioners, physician’s assistants and cardiovascular nurse practitioners and technologists caring for patients with cardiac rhythm management. Prices:MD/ PhD: USD 990.0,NP, PA, RN and allied health staff: USD 900.0. Time: 8:00 am to 11:30 am. Venue details: Sofitel New York, 45 West 44th Street, New York, 10036, United States.